Clinical Performance Evaluation of the Bio-Self™ COVID-19 Antigen Home Test
Sponsor: BioTeke USA, LLC
Listed as NCT05334758, this NA trial focuses on COVID-19 and remains completed. Sponsored by BioTeke USA, LLC, it has been updated 8 times since 2022, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2024 — Jul 2024 [monthly]
Completed NA
-
Aug 2023 — Apr 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Mar 2023 — Aug 2023 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Sep 2022 — Mar 2023 [monthly]
Recruiting NA
-
Jun 2022 — Sep 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
May 2022 — Jun 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- BioTeke USA, LLC
- CSSi Life Sciences
For direct contact, visit the study record on ClinicalTrials.gov .